Maternal deaths in women with lupus nephritis: a review of published evidence.

Abstract:

BACKGROUND AND OBJECTIVES:Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to perform a literature review of the maternal deaths in women with SLE and lupus nephritis to: (1) identify the main causes of death and (2) discuss possible reasons for these causes, and strategies that may improve patient care and outcomes. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENT: We performed an extensive electronic literature search from 1962 to 2009 using online databases (PubMed, Embase, Lilacs, Cochrane Controlled Trials Register, Medline, and Science Citation Index). Studies were included if they reported pregnancies in patients with SLE and lupus nephritis with at least one reported maternal death. RESULTS:We identified 13 studies that reported a total of 17 deaths in the 6 week post-partum period that were attributable to SLE and lupus nephritis. In all cases, death occurred in the setting of active disease, and was attributed either to infection in 41.2% (n = 7), or disease activity in 29.4% (n = 5). The remaining deaths were due to pulmonary embolus in 11.8% (n = 2), pregnancy-associated cardiomyopathy in 5.9% (n = 1), adrenal failure due to abrupt steroid withdrawal in 5.9% (n = 1), and undefined in 5.9% (n = 1). CONCLUSIONS:All maternal deaths in patients with SLE and lupus nephritis occurred in those with active disease, with disease activity/complications and infections (mainly opportunistic) being the two major causes. The presented evidence further supports timing of pregnancy relative to SLE activity, and the judicious use of immunosuppressive agents in pregnant patients.

journal_name

Lupus

journal_title

Lupus

authors

Ritchie J,Smyth A,Tower C,Helbert M,Venning M,Garovic V

doi

10.1177/0961203311434939

subject

Has Abstract

pub_date

2012-04-01 00:00:00

pages

534-41

issue

5

eissn

0961-2033

issn

1477-0962

pii

0961203311434939

journal_volume

21

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • Fibromyalgia in Indian patients with SLE.

    abstract::One hundred and fifty-eight patients with SLE were prospectively studied at a tertiary referral centre in India to ascertain the prevalence and clinical profile of fibromyalgia (FM) in Indian patients with lupus. An attempt was made to determine whether socio-demographic factors or disease characteristics differ in SL...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920497

    authors: Handa R,Aggarwal P,Wali JP,Wig N,Dwivedi SN

    更新日期:1998-01-01 00:00:00

  • Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

    abstract:OBJECTIVES:Systemic lupus erythematosus (SLE) is a chronic, multisystemic, immune-mediated disorder associated with a substantial hospitalization risk. As a comparatively rare disease, there is a sparsity of research examining the burden of hospital admission in the contemporary era. We aim to describe national trends ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319853357

    authors: Hannah J,Galloway J,Kaul A

    更新日期:2019-06-01 00:00:00

  • Infant perinatal thrombosis and antiphospholipid antibodies: a review.

    abstract::Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops feta...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203307079039

    authors: Boffa MC,Lachassinne E

    更新日期:2007-01-01 00:00:00

  • High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is an immune-mediated disease that is responsive to suppression or modulation of the immune system. Patients with SLE who experience persistent multiorgan dysfunction, despite standard doses of intravenous cyclophosphamide (Cy), represent a subset of patients at high risk of early de...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu491oa

    authors: Lisukov IA,Sizikova SA,Kulagin AD,Kruchkova IV,Gilevich AV,Konenkova LP,Zonova EV,Chernykh ER,Leplina OY,Sentyakova TN,Demin AA,Kozlov VA

    更新日期:2004-01-01 00:00:00

  • Neurologic manifestations of antiphospholipid syndrome.

    abstract::Neurological involvement in antiphospholipid antibody syndrome (APS) is common, and its occurrence increases morbidity and mortality. Patients may present variable neurological involvement, such as cerebrovascular disease, cognitive dysfunction, headache, seizures, movement disorders, multiple sclerosis-like syndrome,...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318776110

    authors: Ricarte IF,Dutra LA,Abrantes FF,Toso FF,Barsottini OGP,Silva GS,de Souza AWS,Andrade D

    更新日期:2018-08-01 00:00:00

  • Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies.

    abstract::Monoclonal antiphospholipid antibodies (aPL) have been utilized to dissect the relationship between their sequence, structure, binding and biological properties relevant to the pathogenesis of the antiphospholipid syndrome. In particular, sequence analysis of aPL has highlighted the clustering of certain amino acid re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309360809

    authors: Lambrianides A,Giles IP

    更新日期:2010-04-01 00:00:00

  • Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.

    abstract:OBJECTIVE:The objective of this study was to analyse autoantibodies' titres modulation during belimumab treatment in 50 patients with systemic lupus erythematosus (SLE). METHODS:Sera were collected at belimumab start (T0) and every six months until the 24th month. Disease activity index (SLEDAI-2K) was analysed at eve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319860191

    authors: Cavazzana I,Kumar R,Pozzari C,Ottaviani R,Fredi M,Piantoni S,Andreoli L,Tincani A,Franceschini F

    更新日期:2019-08-01 00:00:00

  • Ultrasonographic abnormalities and inter-reader reliability in Danish patients with systemic lupus erythematosus - a comparison with clinical examination of wrist and metacarpophalangeal joints.

    abstract:OBJECTIVES:We aimed to determine 1) ultrasound (US) abnormalities in patients with systemic lupus erythematosus (SLE) with and without hand arthralgia at the day of examination compared with clinical evaluation and healthy controls, and 2) inter-observer reliability of the US abnormalities. METHODS:Thirty-three female...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314561666

    authors: Dreyer L,Jacobsen S,Juul L,Terslev L

    更新日期:2015-06-01 00:00:00

  • Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).

    abstract::We studied IgG and IgM anticardiolipin antibodies (aCL) by an ELISA method in 80 Mexican systemic lupus erythematosus (SLE) patients and 378 of their first degree relatives. Sixty five percent of SLE patients and 16% of their relatives were positive for aCL. We also determined allele and haplotype frequencies of Major...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600108

    authors: Granados J,Vargas-Alarcón G,Drenkard C,Andrade F,Melín-Aldana H,Alcocer-Varela J,Alarcón-Segovia D

    更新日期:1997-01-01 00:00:00

  • The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review.

    abstract::Pericardial effusions causing pericardial tamponade are rare in patients with systemic lupus erythematosus (SLE). The goal of this study is to describe in detail the clinical and laboratory characteristics of a group of patients with pericardial effusions and pericardial tamponade secondary to SLE. We retrospectively ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308100659

    authors: Rosenbaum E,Krebs E,Cohen M,Tiliakos A,Derk CT

    更新日期:2009-06-01 00:00:00

  • Comparison of articular manifestations of mixed connective tissue disease and systemic lupus erythematosus on clinical examination and musculoskeletal ultrasound.

    abstract:BACKGROUND:Polyarthritis is common to both mixed connective tissue disease (MCTD) and systemic lupus erythematosus (SLE). Apart from being erosive and deforming in the former, we speculated that it was more common and the extent of joints involved would be higher in MCTD. METHODS:This was a cross-sectional study that ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318804891

    authors: Gunashekar S,Prakash M,Minz RW,Sharma A,Sharma S,Dhir V

    更新日期:2018-11-01 00:00:00

  • Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial.

    abstract:INTRODUCTION:Creatine supplementation has emerged as a promising non-pharmacological therapeutic strategy to counteract muscle dysfunction and low lean mass in a variety of conditions, including in pediatric and rheumatic diseases. The objective of this study was to examine the efficacy and safety of creatine supplemen...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203314546017

    authors: Hayashi AP,Solis MY,Sapienza MT,Otaduy MC,de Sá Pinto AL,Silva CA,Sallum AM,Pereira RM,Gualano B

    更新日期:2014-12-01 00:00:00

  • Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody.

    abstract::We describe a patient with rheumatoid arthritis (RA) whose sera contained a high titre of an antibody targeting cytoplasmic ribosomal P proteins (anti-P). This association preceded by 6 years the development of serological and clinical manifestations of systemic lupus erythematosus (SLE). The clinical significance of ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600910

    authors: Hamasaki K,Mimura T,Kanda H,Morino N,Yazaki Y,Nojima Y

    更新日期:1997-01-01 00:00:00

  • 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.

    abstract::Obstetric antiphospholipid syndrome (APS) remains a clinical challenge for practitioners, with several controversial points that have not been answered so far. This Obstetric APS Task Force met on the 16th International Congress on Antiphospholipid Antibodies in Manchester, England, to discuss about treatment, diagnos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320954520

    authors: de Jesús GR,Benson AE,Chighizola CB,Sciascia S,Branch DW

    更新日期:2020-10-01 00:00:00

  • Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study.

    abstract:BACKGROUND:This study aimed to investigate whether early eradication therapy influences systemic lupus erythematosus (SLE) risk in patients with Helicobacter pylori (HP) infection. METHODS:We identified 41,653 patients with HP infection in Taiwan from 2000 to 2013. The patient population was divided into early (within...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320923393

    authors: Wu MC,Huang JY,Chen HH,Wei JC

    更新日期:2020-06-01 00:00:00

  • Interstitial inflammation and long-term renal outcomes in lupus nephritis.

    abstract:INTRODUCTION:The International Society of Nephrology/Renal Pathology Society (ISN/RPS) pathological classification criteria of lupus nephritis are limited to glomerular injury. Although the tubulointerstitium is commonly involved, the importance of such involvement is not well defined. The major objective of this study...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313507986

    authors: Alsuwaida AO

    更新日期:2013-12-01 00:00:00

  • Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.

    abstract::The objective of this article was to evaluate whether serum uric acid (SUA) correlates with arterial stiffness and inflammation markers in a cohort of women with systemic lupus erythematosus (SLE) without overt atherosclerotic cardiovascular diseases, who attended a community hospital. One hundred and two women with S...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309355301

    authors: Sabio JM,Vargas-Hitos JA,Mediavilla JD,Navarrete-Navarrete N,Zamora-Posadas M,Pérez-Vicente S,Hidalgo-Tenorio C,Díaz-Chamorro A,Jáimez L,Jiménez-Alonso J,Grupo Lupus Virgen de las Nieves.

    更新日期:2010-04-01 00:00:00

  • Repeated miscarriages in patients with antiphospholipid syndrome and subjected to in vitro fertilization: the importance of preimplantation genetic diagnosis.

    abstract::The aim of this study was to investigate two patients with antiphospholipid syndrome (APS) who suffered from multiple repeated pregnancy losses of probably genetically impaired embryos. Sera from these patients contained high levels of IgG antibodies against cardiolipin, IgG and IgM phosphatidyl inositol, IgG phosphat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312442581

    authors: Ulcova-Gallova Z

    更新日期:2012-06-01 00:00:00

  • The role of anti-malarials in rheumatoid arthritis--the American experience.

    abstract::Rheumatoid Arthritis (RA) is a chronic disease with significant morbidity and functional disability. The traditional treatment for RA relied on the use of NSAIDs early in the disease course, followed by disease-modifying agents later. More recently, the disease-modifying anti-rheumatic drugs (DMARDs) have become the m...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:

    authors: Khraishi MM,Singh G

    更新日期:1996-06-01 00:00:00

  • The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center.

    abstract::We retrospectively evaluated the clinical outcome of 45 female and 11 male patients with biopsy-proven lupus nephritis, followed at our hospital between February 1974 and February 1990. In the majority signs of nephritis were present at the time systemic lupus erythematosus was diagnosed (range: -42-156 months) and th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100207

    authors: Derksen RH,Hené RJ,Kater L

    更新日期:1992-02-01 00:00:00

  • Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.

    abstract::Vaccination has been perhaps the most important achievement in medicine of the last century. A hoard of infectious diseases that used to claim the lives of many, especially children, have been prevented and some even eradicated. However, it is possible that within this gift there is hidden a 'Trojan Horse'. During the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301673085478

    authors: Aron-Maor A,Shoenfeld Y

    更新日期:2001-01-01 00:00:00

  • Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.

    abstract::We investigated the clinical significance of IgG phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera were examined for IgG phospholipid-dependent anti-beta 2-GPI antibodies by ELISA. IgG phospholipid-dependent ant...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400609

    authors: Kaburaki J,Kuwana M,Yamamoto M,Kawai S,Matsuura E,Ikeda Y

    更新日期:1995-12-01 00:00:00

  • T cell vaccination in systemic lupus erythematosus with autologous activated T cells.

    abstract::Systemic lupus erythematosus (SLE) is an autoreactive T cell mediated autoimmune disease. Immunization with inactivated autoreactive T cells may induce idiotype anti-idiotypic reaction to deplete specific subsets of autoreactive T cells involved in SLE. Six SLE patients unsuitable or refused to use immunosuppressants ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203305lu2239oa

    authors: Li ZG,Mu R,Dai ZP,Gao XM

    更新日期:2005-01-01 00:00:00

  • Anti-α-enolase antibody combined with β2 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients.

    abstract:OBJECTIVE:Anti-α-enolase antibody (Ab) combined with β2 microglobulin (β2-MG) were investigated to predict the incidence of nephritis in systemic lupus erythematosus (SLE) patients. METHODS:Levels of serum anti-α-enolase Ab and urinary β2-MG were detected in 115 SLE patients, 29 SLE patients with nephritis and 70 heal...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319828822

    authors: Huang Y,Chen L,Chen K,Huang F,Feng Y,Xu Z,Wang W

    更新日期:2019-03-01 00:00:00

  • Interleukin-2 and systemic lupus erythematosus--fifteen years later.

    abstract::Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder in which multiple immunologic abnormalities have been described. In this review, we thoroughly analyse the impaired T cell production of, and response to, interleukin-2 (IL-2) characteristic of patients with SLE. Since it was first reported, several...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920028

    authors: Crispin JC,Alcocer-Varela J

    更新日期:1998-01-01 00:00:00

  • Innate immunity and atherogenesis.

    abstract::Atherosclerosis is recognized as the pathological basis of cardiovascular disease (CVD) and recent advances in basic science have shown that it should be considered as a chronic inflammatory process. Both elements of the innate and the adaptive immunity appear to be actively involved in atherogenesis. In fact, the pot...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2213oa

    authors: Rattazzi M,Faggin E,Bertipaglia B,Pauletto P

    更新日期:2005-01-01 00:00:00

  • Cytomegalovirus infection in Systemic Lupus Erythematosus: report of four cases challenging the management of the disease, and literature review.

    abstract::Cytomegalovirus (CMV) is particularly dangerous in systemic lupus erythematosus (SLE), being a problem both for the differential diagnosis with disease flare and for the management of SLE flare with immunosuppressive drugs. We report on four cases of SLE with concomitant CMV infection, having some common clinical and ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319825570

    authors: Sebastiani GD,Iuliano A,Canofari C,Bracci M

    更新日期:2019-03-01 00:00:00

  • The significance of anticardiolipin antibodies in patients with lupus nephritis.

    abstract::The objective of this study was to determine whether anticardiolipin antibodies (ACL) in SLE patients are associated with a specific pattern of lupus nephritis and/or with renal microvascular changes. Patients with SLE, followed prospectively between June 1991-May 1994 at The Wellesley Hospital Lupus Clinic, who under...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500113

    authors: Abu-Shakra M,Urowitz MB,Gladman DD,Ritchie S

    更新日期:1996-02-01 00:00:00

  • Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.

    abstract::C4d deposition in peritubular capillaries (PTC) has been used as a marker of antibody-mediated rejection (AMR). However, PTC C4d deposition is not described in patients with lupus nephritis (LN). C4d deposition in PTC was detected in 455 patients with biopsy proven LN in the present study. Renal tissues from 21 cases ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307083279

    authors: Li SJ,Liu ZH,Zen CH,Wang QW,Wang Y,Li LS

    更新日期:2007-01-01 00:00:00

  • Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is characterized by the finding of ample serum autoantibodies. The role and the origin of many of these antibodies are still obscure. The aim of this work was to study the occurrence of anti-insulin antibodies (AIA) in SLE, and to postulate, based on AIA determination, on the mechani...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301669081314

    authors: Lidar M,Braf A,Givol N,Langevitz P,Pauzner R,Many A,Livneh A

    更新日期:2001-01-01 00:00:00